A critique of the second consensus criteria for multiple system atrophy

TLDR

The aim of this study was to establish a baseline level of confidence in the ability of the participants to identify and treat Movement Disorder Society Multiple System Atrophy patients with atrophy.

Abstract

Iva Stankovic, MD, Niall Quinn, MD, Luca Vignatelli, MD, Angelo Antonini, MD, Daniela Berg, MD, PhD, Elizabeth Coon, MD, Pietro Cortelli, MD, Alessandra Fanciulli, MD, PhD, Joaquim J. Ferreira, MD, PhD, Roy Freeman, MD, Glenda Halliday, MD, Günter U. Höglinger, MD, Valeria Iodice, MD, Horacio Kaufmann, MD, Thomas Klockgether, MD, Vladimir Kostic, MD, PhD, Florian Krismer, MD, PhD, Anthony Lang, MD, Johannes Levin, MD, Phillip Low, MD, Christopher Mathias, MD, Wassillios G. Meissner, MD, PhD, Lucy Norcliffe Kaufmann, PhD, Jose-Alberto Palma, MD, PhD, Jalesh N. Panicker, MD, FRCP, Maria Teresa Pellecchia, MD, PhD, Ryuji Sakakibara, MD, PhD, Jeremy Schmahmann, MD, Sonja W. Scholz, MD, PhD, Wolfgang Singer, MD, Maria Stamelou, MD, PhD, Eduardo Tolosa, MD, Shoji Tsuji, MD,PhD, Klaus Seppi, MD, PhD, Werner Poewe, MD, and Gregor K. Wenning, MD, PhD,* on behalf of the Movement Disorder Society Multiple System Atrophy Study Group